Cargando…

Transparency in Negotiation of European Union With Big Pharma on COVID-19 Vaccines

Detalles Bibliográficos
Autores principales:	Sciacchitano, Salvatore, Bartolazzi, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930234/ https://www.ncbi.nlm.nih.gov/pubmed/33681138 http://dx.doi.org/10.3389/fpubh.2021.647955

Ejemplares similares

Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States
por: Montano, Diego
Publicado: (2022)

Big Pharma (The Play)
por: Bero, Lisa
Publicado: (2007)

Sustainable Health and Wellbeing in the European Union
por: Gavurova, Beata, et al.
Publicado: (2022)

COVID-19 vaccine inequity and Big Pharma: time to rethink our love affair?
por: Ali, Shehzad, et al.
Publicado: (2022)

Moving the needle for COVID-19 vaccinations in Nigeria through leadership, accountability, and transparency
por: Ojeniyi, Toluwanimi, et al.
Publicado: (2023)

Greenhouse Gas Emissions and Health in the Countries of the European Union
por: Gavurova, Beata, et al.
Publicado: (2021)

Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
por: Okereke, Melody
Publicado: (2021)

Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021)

The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies
por: Gontariuk, Marie, et al.
Publicado: (2021)

Causes and circumstances of accidents at work in the European Union, Slovakia and Czech Republic
por: Hollá, Katarína, et al.
Publicado: (2023)

Big Pharma, Big Bucks, and a Big Pile o' Pigs
Publicado: (2001)

Galectin-3: The Impact on the Clinical Management of Patients with Thyroid Nodules and Future Perspectives
por: Bartolazzi, Armando, et al.
Publicado: (2018)

Big Pharma holt sich blaues Auge
por: Martens, Peter
Publicado: (2021)

BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

The Companion Pandemic to COVID-19: The Use of Informal Practices to Access Public Healthcare Services in the European Union
por: Horodnic, Adrian V., et al.
Publicado: (2022)

Highly varying concepts and capacities of forensic mental health services across the European Union
por: Salize, Hans Joachim, et al.
Publicado: (2023)

Citizen engagement initiatives in precision health in the European Union member states: a scoping review
por: Pezzullo, Angelo Maria, et al.
Publicado: (2021)

Status and contents of physical activity recommendations in European Union countries: a systematic comparative analysis
por: Gelius, Peter, et al.
Publicado: (2020)

How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study
por: Mahrouseh, Nour, et al.
Publicado: (2022)

Real-Time Analysis of Predictors of COVID-19 Infection Spread in Countries in the European Union Through a New Tool
por: Balogh, Aniko, et al.
Publicado: (2022)

European Union Structural Funds as the Source of Financing Health Care Infrastructure Investments in Poland—A Longitudinal Analysis
por: Dubas-Jakóbczyk, Katarzyna, et al.
Publicado: (2022)

Protecting public health and the environment: towards a general ban on cellulose acetate cigarette filters in the European Union
por: Everaert, Stijn, et al.
Publicado: (2023)

First cross-border outbreak of foodborne botulism in the European Union associated with the consumption of commercial dried roach (Rutilus rutilus)
por: Hendrickx, David, et al.
Publicado: (2023)

Epidemiological Predictive Modeling of COVID-19 Infection: Development, Testing, and Implementation on the Population of the Benelux Union
por: Šušteršič, Tijana, et al.
Publicado: (2021)

Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
por: Yang, Xiaorong, et al.
Publicado: (2022)

Population health differences in cross-border regions within the European Union and Schengen area: a protocol for a scoping review
por: Stroisch, Sophie, et al.
Publicado: (2023)

Accounting Transparency, Fear Sentiment and the COVID-19 Epidemic: For Public Health Security and the Construction of an Early Warning System
por: Wang, Haiyan, et al.
Publicado: (2022)

COVID-19 vaccination roll-outs in eleven small countries within the WHO European region; Lessons learned
por: Palmer, Katie, et al.
Publicado: (2022)

Follow-on Biologics: A New Play for Big Pharma: Healthcare 2010
por: Evans, Ian
Publicado: (2010)

Screening of Big Pharma’s Library against Various in-house Biological Targets
por: Knez, Damijan, et al.
Publicado: (2022)

The History of Anthrax Weaponization in the Soviet Union
por: Nikolakakis, Ioannis, et al.
Publicado: (2023)

Impact of COVID 19 Pandemic and Big Data on China's International Trade: Challenges and Countermeasures
por: Zhao, Shuang
Publicado: (2022)

Analysis of COVID-19 outbreak in Hubei province based on Tencent's location big data
por: Hua, Lei, et al.
Publicado: (2023)

Industry strategies to market opioids to children and women in the USA: a content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P. et al
por: Yakubi, Hanna, et al.
Publicado: (2022)

Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis
por: Liu, Yanyan, et al.
Publicado: (2022)

The Image of Pharma
Publicado: (2007)

Pharma-Ecology
por: Jjemba, Patrick
Publicado: (2018)

Protecting public’s wellbeing against COVID-19 infodemic: The role of trust in information sources and rapid dissemination and transparency of information over time
por: Zhou, Yingnan, et al.
Publicado: (2023)

Side effect profile prediction - early addressing of big pharma's worst nightmare
por: Scheiber, J, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dfmui42qdbbnauaccvsgtnko4c